Riskpilot← Back to searchSign inGet full accessSkalpell & Sutur AB
ABActiveOrg 5592470909Fredriksdalsgatan 14Medical specialists activities · NACE 8622Est. 202011 employees
Revenue 2024
SEK 15,3M
-50% vs 2023
EBITDA margin
-44.3%
-99% vs 2023
Equity ratio
-94.3%
Financial strength
Net profit 2024
SEK -2,5M
+32% vs 2023
| Revenue | SEK 15,3M | -50% |
| EBITDA | SEK -6,8M | -99% |
| Net profit | SEK -2,5M | +32% |
| Total assets | SEK 2,6M | -46% |
| Equity | SEK -2,5M | -5824% |
| Employees | 11 | — |
Legal name
Skalpell & Sutur AB
Org number
5592470909
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 mars 2020
Share capital
SEK 25 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall omfatta plastikkirurgi samt därmed förenlig verksamhet.
Address
Fredriksdalsgatan 14
Email
tobias@plastikkirurgen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 121 | 16 647 | 30 664 | 15 296 |
| Staff expenses | — | −3 799 | −7 246 | −5 494 |
| EBITDA | −2 154 | 78 | −3 403 | −6 780 |
| Depreciation & amort. | −5 | −51 | −161 | −116 |
| EBIT | −2 159 | 27 | −3 564 | −6 897 |
| Net financials | −68 | −39 | −129 | −207 |
| Profit before tax | −2 227 | −12 | −3 692 | −2 504 |
| Tax | −0 | — | — | — |
| Net profit | −2 227 | −12 | −3 692 | −2 504 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 2 372 | 4 333 | 4 832 | 2 610 |
| Equity | 98 | 85 | 43 | −2 461 |
| Long-term debt | 575 | 275 | 293 | 293 |
| Short-term debt | 1 700 | 3 972 | 4 496 | 4 778 |
| Total debt | 2 275 | 4 247 | 4 789 | 5 071 |
EBITDA margin
-44.3%
This company
15.8%
Market median
-380% vs market
20212024
Equity ratio
-94.3%
This company
38.2%
Market median
-347% vs market
20212024
Return on equity
-250441600.0%
This company
18.4%
Market median
-1361095752% vs market
20212024
Net profit margin
-16.4%
This company
8.1%
Market median
-302% vs market
20212024
Asset turnover
5.86×
This company
1.12×
Market median
+423% vs market
20212024
Debt / equity
2.06×
This company
0.62×
Market median
-232% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BJ | Audit | 2022 |
| Former (1) | ||
PA Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (4) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 95% | 95% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tobias L Invest AB
Skalpell & Sutur AB Board members of Skalpell & Sutur AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Arne Pieter Bodfält | Chief Executive Officer | 0 companies |
| Björn Joakim Bråtemyr | Audit | 0 companies |
| Per Viktor Morin | Deputy Board Member | 0 companies |
| Leif Olov Gylbert | Board of Directors | 0 companies |
| Bo Jesper Georgii-Hemming | Board of Directors | 0 companies |
| Per Henrik Lundström | Deputy Board Member | 0 companies |
| Lena Kristin Eld Gylbert | Deputy Board Member | 0 companies |
| Karl Gustaf Tobias Bowallius Lange | Board of Directors | 0 companies |